MissionIR Articles
-
MissionIRNewsBreaks – Knightscope Inc. Featured in Broadcast Discussing Innovative Machine-as-a-Service Business Model
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today announced the availability of a broadcast titled, “Creating Shareholder Value with a Machine-as-a-Service (‘MaaS’) Business Model.” The piece covers various aspects of the new-era model, stating, “Knightscope’s autonomous security robots (‘ASRs’) represent the next generation of innovation that the stagnant…
-
MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Leaders to Present at Upcoming Virtual Investor Summit
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”) has announced that CEO Kirk Huntsman, CFO Brad Amman and investor relations officer Ed Loew are scheduled to present at the Q1 Virtual Investor Summit. Vivos Therapeutics’ presentation is…
-
MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) Company Founder Scheduled to Present at Upcoming Investor Summit
PlantX Life (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has announced that its founder, Sean Dollinger, will be presenting at the Q1 Virtual Investor Summit. The three-day summit is slated for March 23–25, 2021. Dollinger’s presentation will begin at 11:30 a.m. ET on March 24th and will include compelling…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Preclinical Data Demonstrating Differentiated Mechanism of Action of PH10 from Benzodiazepines
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced promising preclinical data for its PH10 drug candidate. The data demonstrate that the potential mechanism of action of PH10, VistaGen’s Phase 2 investigational pherine nasal spray with potential as a rapid-onset, stand-alone treatment…
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen to Purchase Mississippi-Based EV Manufacturing Facility
Net Element (NASDAQ: NETE) is in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. Mullen today announced that it has executed a purchase and sales agreement (“PSA”) and opened escrow to purchase an EV manufacturing facility in Tunica, Mississippi.…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Appointment of Entrepreneur and Visionary Brock Pierce
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, today announced that Brock Pierce, the entrepreneur, philanthropist and 2020 presidential candidate, has joined its board of directors. According to the update, Pierce has co-founded, advised and funded over 100 companies to support the creation of new jobs and…
-
MissionIRNewsBreaks – Knightscope Inc. Announces Target Closing Date for Regulation A+ Offering
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has published an update regarding its recent regulatory filing with the U.S. Securities & Exchange Commission (“SEC”) and announced a target closing date of April 21, 2021, for its current Regulation A+ offering. The update reads, “Over 20,000 people have invested…
-
MissionIRNewsBreaks – Why Uranium Energy Corp. (NYSE American: UEC) Is ‘One to Watch’
Uranium Energy (NYSE American: UEC) is a Corpus Christi, Texas-based uranium mining and exploration company that controls one of the largest historical uranium exploration and development databases in the United States. The company’s acquired properties are primarily located within the U.S., including Texas, New Mexico, Colorado, Arizona and Wyoming. Through leveraging historical exploration data, UEC…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Stifel GMP Conference
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Stifel GMP Health Care Conference – Health Care Psychedelics: Addressing the Global Mental Health Crisis. Drysdale’s presentation is scheduled to begin at 1:00…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Partners with Oracle to Offer Oracle CX Suite
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China and a member of Oracle PartnerNetwork (“OPN”) is working with Oracle to develop a powerful tailored SaaS offering that empowers companies to better serve and connect with consumers in China. Oracle is a leading integrated cloud applications and platform services provider. The…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates to Advance Commercialization of Patented UST Platform
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently announced a strategic agreement for the implementation of PBI’s patented Ultra Shear Technology(TM) (“UST”) platform. PBI is developing three different…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials
CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation clears the way for the company to start human clinical trials and to ship the experimental drug across state lines…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference is slated for March 17–18, 2021. During the online event, all registered attendees will be able to access Sapirstein’s presentation…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Host Q4 and Full-Year 2020 Results Conference Call
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter and year ended December 31, 2020. The call, to be hosted by Sigma Labs president and CEO Mark Ruport and…
-
MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announced Partner Has Received ISO Certification for Rapid COVID-19 Test
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH (“3a”) has received EN ISO 13485 certification for its rapid point-of-care, SARS-CoV-2 RT-PCR Test System (“Covid-ID Lab”). 3a-diagnostics is XPhyto’s exclusive German diagnostics development partner. In addition the…
-
MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA 510(k) Application for Exclusive Oral Appliance
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), recently submitted an application to the U.S. Food and Drug Administration (“FDA”) for its mmRNA (“mmRNA”) oral appliance(TM). The 510(k) Class II application focuses on the oral appliance as…
-
MissionIRNewsBreaks – Ideanomics (NASDAQ: IDEX) Acquires 20% Stake in Energica Motor Company
Ideanomics (NASDAQ: IDEX) today announced that it has acquired 20% of Italian Energica Motor Company S.p.A., a developer of high-performance, 100% battery-powered motorbikes, for the consideration of $13.2 million. With this move, which marks continued investment in European-based OEM, Ideanomics expands its global footprint in the electric vehicle (“EV”) industry. “Energica has combined zero emissions…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports Q4, FY 2020 Numbers, Business Highlights
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its financial and business update report for the fourth quarter and full year 2020. The company reports significant progress across all aspects of its long-term strategic operating plan, including securing several accounts in the B2B (“B2B”) channel that are generating revenue and…
-
MissionIRNewsBreaks – Brain Scientific Inc. (BRSF) Secures FDA Clearance for Next-Gen NeuroCap(TM)
Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, today announced its receipt of U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its next-generation NeuroCap(TM) device. NeuroCap is an advanced electroencephalogram (“EEG”) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Begin Commercial Recovery of Rare Earths in Coming Weeks
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and critical minerals in the United States, today announced that the first shipments of natural monazite ore arrived this past weekend at the company’s White Mesa Mill in Blanding, Utah. According to the update, the material was separated by The Chemours Company at…
Search Articles
Latest Articles
- MissionIRNewsBreaks – The Wendy’s Company (NASDAQ: WEN) Reports Q3 Results, Highlights International Momentum and U.S. Operational Gains
- MissionIRNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Eyes Opportunity in Next Phase of the Digital Revolution
- Beeline Holdings Inc. (NASDAQ: BLNE) Reaches Cash-Flow Milestone as Growth Strategy Gains Traction
- Datavault AI Inc. (NASDAQ: DVLT) CEO Featured in Interview Highlighting Vision for Ethical, Accessible and Monetizable Artificial Intelligence
- MissionIRNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Sets Dec. 2 Conference Call to Discuss Solana Treasury Strategy